210 related articles for article (PubMed ID: 35740635)
1. Validation of a Patient-Derived Xenograft Model for Cervical Cancer Based on Genomic and Phenotypic Characterization.
Miyamoto S; Tanaka T; Hirosuna K; Nishie R; Ueda S; Hashida S; Terada S; Konishi H; Kogata Y; Taniguchi K; Komura K; Ohmichi M
Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740635
[TBL] [Abstract][Full Text] [Related]
2. Consistency between Primary Uterine Corpus Malignancies and Their Corresponding Patient-Derived Xenograft Models.
Ueda S; Tanaka T; Hirosuna K; Miyamoto S; Murakami H; Nishie R; Tsuchihashi H; Toji A; Morita N; Hashida S; Daimon A; Terada S; Maruoka H; Kogata Y; Taniguchi K; Komura K; Ohmichi M
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338763
[TBL] [Abstract][Full Text] [Related]
3. Establishment and genetically characterization of patient-derived xenograft models of cervical cancer.
Zou S; Ye M; Zhang JA; Ji H; Chen Y; Zhu X
BMC Med Genomics; 2022 Sep; 15(1):191. PubMed ID: 36076209
[TBL] [Abstract][Full Text] [Related]
4. Establishment of a high-fidelity patient-derived xenograft model for cervical cancer enables the evaluation of patient's response to conventional and novel therapies.
Liu L; Wu M; Huang A; Gao C; Yang Y; Liu H; Jiang H; Yu L; Huang Y; Wang H
J Transl Med; 2023 Sep; 21(1):611. PubMed ID: 37689699
[TBL] [Abstract][Full Text] [Related]
5. Patient-derived non-small cell lung cancer xenograft mirrors complex tumor heterogeneity.
Chen X; Shen C; Wei Z; Zhang R; Wang Y; Jiang L; Chen K; Qiu S; Zhang Y; Zhang T; Chen B; Xu Y; Feng Q; Huang J; Zhong Z; Li H; Che G; Xiao K
Cancer Biol Med; 2021 Feb; 18(1):184-198. PubMed ID: 33628593
[TBL] [Abstract][Full Text] [Related]
6. Patient-Derived Xenograft Models in Cervical Cancer: A Systematic Review.
Tanaka T; Nishie R; Ueda S; Miyamoto S; Hashida S; Konishi H; Terada S; Kogata Y; Sasaki H; Tsunetoh S; Taniguchi K; Komura K; Ohmichi M
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502278
[TBL] [Abstract][Full Text] [Related]
7. Patient-derived xenograft models for gastrointestinal tumors: A single-center retrospective study.
Yu X; Chen Y; Lu J; He K; Chen Y; Ding Y; Jin K; Wang H; Zhang H; Wang H; Teng L
Front Oncol; 2022; 12():985154. PubMed ID: 36465411
[TBL] [Abstract][Full Text] [Related]
8. Establishment and evaluation of retroperitoneal liposarcoma patient-derived xenograft models: an ideal model for preclinical study.
Xu C; Yan L; An Q; Zhang S; Guan X; Wang Z; Lv A; Liu D; Liu F; Dong B; Zhao M; Tian X; Hao C
Int J Med Sci; 2022; 19(8):1241-1253. PubMed ID: 35928724
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive comparison of patient-derived xenograft models in Hepatocellular Carcinoma and metastatic Liver Cancer.
Xu W; Zhao ZY; An QM; Dong B; Lv A; Li CP; Guan XY; Tian XY; Wu JH; Hao CY
Int J Med Sci; 2020; 17(18):3073-3081. PubMed ID: 33173428
[TBL] [Abstract][Full Text] [Related]
10. Establishment and preclinical application of a patient-derived xenograft model for uterine cancer.
Jeong SY; Cho YJ; Ryu JY; Choi JJ; Hwang JR; Kim B; Lee YY; Kim HS; Lee JW
Gynecol Oncol; 2021 Jul; 162(1):173-181. PubMed ID: 33972086
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional dissection of pancreatic tumors engrafted in mice.
Martinez-Garcia R; Juan D; Rausell A; Muñoz M; Baños N; Menéndez C; Lopez-Casas PP; Rico D; Valencia A; Hidalgo M
Genome Med; 2014; 6(4):27. PubMed ID: 24739241
[TBL] [Abstract][Full Text] [Related]
12. An improved method to build lung cancer PDX models by surgical resection samples and its association with B7-H3 expression.
Wang Y; Zhang B; Huang H; Wang T
Transl Cancer Res; 2019 Dec; 8(8):2848-2857. PubMed ID: 35117042
[TBL] [Abstract][Full Text] [Related]
13. Establishment of Patient-Derived Tumor Xenograft Models of High-Risk Endometrial Cancer.
Zhu M; Jia N; Nie Y; Chen J; Jiang Y; Lv T; Li Y; Yao L; Feng W
Int J Gynecol Cancer; 2018 Nov; 28(9):1812-1820. PubMed ID: 30358704
[TBL] [Abstract][Full Text] [Related]
14. Establishment of an orthotopic patient-derived xenograft mouse model using uveal melanoma hepatic metastasis.
Kageyama K; Ohara M; Saito K; Ozaki S; Terai M; Mastrangelo MJ; Fortina P; Aplin AE; Sato T
J Transl Med; 2017 Jun; 15(1):145. PubMed ID: 28645290
[TBL] [Abstract][Full Text] [Related]
15. Creation and Validation of Patient-Derived Cancer Model Using Peritoneal and Pleural Effusion in Patients with Advanced Ovarian Cancer: An Early Experience.
Nishie R; Tanaka T; Hirosuna K; Miyamoto S; Murakami H; Tsuchihashi H; Toji A; Ueda S; Morita N; Hashida S; Daimon A; Terada S; Maruoka H; Konishi H; Kogata Y; Taniguchi K; Komura K; Ohmichi M
J Clin Med; 2024 May; 13(9):. PubMed ID: 38731247
[No Abstract] [Full Text] [Related]
16. Tumor characteristics associated with engraftment of patient-derived non-small cell lung cancer xenografts in immunocompromised mice.
Chen Y; Zhang R; Wang L; Correa AM; Pataer A; Xu Y; Zhang X; Ren C; Wu S; Meng QH; Fujimoto J; Jensen VB; Antonoff MB; Hofstetter WL; Mehran RJ; Pisimisis G; Rice DC; Sepesi B; Vaporciyan AA; Walsh GL; Swisher SG; Roth JA; Heymach JV; Fang B
Cancer; 2019 Nov; 125(21):3738-3748. PubMed ID: 31287557
[TBL] [Abstract][Full Text] [Related]
17. Patient-Derived Xenograft Models for Intrahepatic Cholangiocarcinoma and Their Application in Guiding Personalized Medicine.
Gao Y; Zhou R; Huang JF; Hu B; Cheng JW; Huang XW; Wang PX; Peng HX; Guo W; Zhou J; Fan J; Yang XR
Front Oncol; 2021; 11():704042. PubMed ID: 34327143
[TBL] [Abstract][Full Text] [Related]
18. Patient-Derived Xenografts Are a Reliable Preclinical Model for the Personalized Treatment of Epithelial Ovarian Cancer.
Chen J; Jin Y; Li S; Qiao C; Peng X; Li Y; Gu Y; Wang W; You Y; Yin J; Shan Y; Wang YX; Qin M; Li H; Cai Y; Dong Y; Peng S; Pan L
Front Oncol; 2021; 11():744256. PubMed ID: 34671560
[TBL] [Abstract][Full Text] [Related]
19. Establishment and Characterization of Advanced Penile Cancer Patient-derived Tumor Xenografts: Paving the Way for Personalized Treatments.
Elst L; Van Rompuy AS; Roussel E; Spans L; Vanden Bempt I; Necchi A; Ross J; Jacob JM; Baietti MF; Leucci E; Albersen M
Eur Urol Focus; 2022 Nov; 8(6):1787-1794. PubMed ID: 35537937
[TBL] [Abstract][Full Text] [Related]
20. Establishment of chemosensitivity tests in triple-negative and BRCA-mutated breast cancer patient-derived xenograft models.
Park HS; Lee JD; Kim JY; Park S; Kim JH; Han HJ; Choi YA; Choi AR; Sohn JH; Kim SI
PLoS One; 2019; 14(12):e0225082. PubMed ID: 31821346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
